Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEF0117 in healthy volunteers
NCT03325595Phase 1Completed
- Sponsor
- Aelis Farma
- Start
- Apr 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of aef0117 in cannabis use disorder (CUD), sponsored by Aelis Farma. Started Apr 2017; status: completed.
02
Drugs
aef0117
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT03325595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03325595.